Loading…

Acalabrutinib Plus Venetoclax and Rituximab in Patients with Treatment-Naïve (TN) Mantle Cell Lymphoma (MCL): 2-Year Safety and Efficacy Analysis

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.6477-6479
Main Authors: Wang, Michael, Robak, Tadeusz, Maddocks, Kami J., Phillips, Tycel, Smith, Stephen D., Gallinson, David, Calvo, Roser, Wun, Chuan-Chuan, Munugalavadla, Veerendra, Jurczak, Wojciech
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-157595